Type 1 diabetes - redGDPS

More documents

Recommendations

Info

Guideline Development Group membership and acknowledgementsNational Council for Disabled People, Black, Minority and Ethnic CommunityNational Public Health ServiceNewcastle PCTNHS Information AuthorityNHS Quality Improvement ScotlandNorfolk and Norwich University Hospital NHS TrustNovo Nordisk LimitedOrtho BiotechPatient Involvement Unit for NICEPfizer LimitedProdigyProvalis Diagnostics LtdRoche Diagnostics LimitedRoyal College of AnaesthetistsRoyal College of General PractitionersRoyal College of General Practitioners WalesRoyal College of MidwivesRoyal College of NursingRoyal College of OphthalmologistsRoyal College of Paediatrics and Child HealthRoyal College of PathologistsRoyal College of Physicians of LondonRoyal College of PsychiatristsRoyal College of Surgeons of EnglandRoyal National Institute of the BlindRoyal Pharmaceutical Society of Great BritainScottish Intercollegiate Guidelines NetworkSheffield Teaching Hospitals NHS TrustSociety of Chiropodists and PodiatristsThe Royal Society of MedicineTissue Viability Nurses AssociationTissue Viability SocietyTOAST (The Obesity Awareness and Solutions Trust)UK National Screening CommitteeUK Pain SocietyUK Thalassaemia SocietyWelsh Assembly Government (formerly National Assembly for Wales)Westmeria Healthcare Ltdvii
AbbreviationsCICGMSCSIIDCCTGDGGPPGRPHbA 1 , HbA 1cIQLSHTMNCBNCC-WCHNICENICE TANNTOGTTORQALYRCTRRSDSEWMDConfidence intervalContinuous glucose monitoring systemContinuous subcutaneous insulin infusionDiabetes Control and Complications TrialGuideline Development GroupGood practice pointGuideline Review PanelGlycated haemoglobinIntelligence quotientLondon School of Hygiene and Tropical MedicineNational Children’s BureauNational Collaborating Centre for Women’s and Children’s HealthNational Institute for Clinical ExcellenceNICE Technology AppraisalNumber needed to treatOral glucose tolerance testOdds ratioQuality-adjusted life yearRandomised controlled (clinical) trialRelative risk (or risk ratio)Standard deviationStandard errorWeighted mean differenceviii
Page 2 and 3: Type 1 diabetes: diagnosisand manag
Page 4 and 5: ContentsGuideline Development Group
Page 6 and 7: Guideline DevelopmentGroup membersh
Page 10 and 11: Glossary of termsBiasBlinding or ma
Page 12 and 13: Glossary of termsCross-sectional st
Page 14 and 15: Glossary of termsPowerProspective s
Page 16: Glossary of termsSystematic reviewV
Page 19 and 20: Type 1 diabetesA separate guideline
Page 21 and 22: Type 1 diabetesTable 1.1 Levels of
Page 23 and 24: Type 1 diabetesTable 1.3Outcome cat
Page 25 and 26: Type 1 diabetesAt the time of diagn
Page 27 and 28: Type 1 diabetesChildren and young p
Page 29 and 30: Type 1 diabetesChildren and young p
Page 31 and 32: Type 1 diabetes• As symptoms impr
Page 33 and 34: Type 1 diabetes6.2 Anxiety and depr
Page 35 and 36: Type 1 diabetes2.2 Future research
Page 39 and 40: 3. Diagnosis and initialmanagement3
Page 41 and 42: Type 1 diabetes• show evidence of
Page 43 and 44: Type 1 diabetespsychosocial support
Page 45 and 46: Type 1 diabetesself-monitoring of b
Page 47 and 48: Type 1 diabetesIndometacinOne RCT h
Page 49 and 50: Type 1 diabetesdiagnosed type 1 dia
Page 51 and 52: Type 1 diabetesdiabetes management.
Page 53 and 54: Type 1 diabetes• advising childre
Page 55 and 56: Type 1 diabetes• initial and cont
Page 57 and 58: Type 1 diabetesyears) involved in t
Page 59 and 60:
Type 1 diabetesThe DCCT found no si
Page 61 and 62:
Type 1 diabetesSpecial insulin regi
Page 63 and 64:
Type 1 diabetesHbA 1c was lower aft
Page 65 and 66:
Type 1 diabetesEstablished users of
Page 67 and 68:
Type 1 diabetesTwo rapid-acting hum
Page 69 and 70:
Type 1 diabeteslevels (7.07 ± 0.51
Page 71 and 72:
Type 1 diabetesThree RCTs reported
Page 73 and 74:
Type 1 diabetesinsulin zinc suspens
Page 75 and 76:
Type 1 diabetes4.4 Methods of deliv
Page 77 and 78:
Type 1 diabeteslooked at the absorp
Page 79 and 80:
Type 1 diabetesDisposal of sharpsA
Page 81 and 82:
Type 1 diabetesThere are several ty
Page 83 and 84:
Type 1 diabeteshypoglycaemia: 1.75
Page 85 and 86:
Type 1 diabetesstorage of blood sam
Page 87 and 88:
Type 1 diabetesThree studies in the
Page 89 and 90:
Type 1 diabetesperformed on a month
Page 91 and 92:
Type 1 diabetesthat a memory was fi
Page 93 and 94:
Type 1 diabetesas well as performin
Page 95 and 96:
Type 1 diabetespackage of care that
Page 97 and 98:
Type 1 diabetesWe found four studie
Page 99 and 100:
Type 1 diabetesChildren and young p
Page 101 and 102:
Type 1 diabetesdiabetes care teams.
Page 103 and 104:
Type 1 diabetesSmokingSmoking has b
Page 105 and 106:
Type 1 diabeteswere hospitalised wi
Page 107 and 108:
Type 1 diabetesWhat is the optimum
Page 109 and 110:
Type 1 diabetesIntranasal glucagon
Page 111 and 112:
Type 1 diabetesadmission for diabet
Page 113 and 114:
Type 1 diabetesContinuous versus in
Page 115 and 116:
Type 1 diabetesSomatostatin therapy
Page 117 and 118:
Type 1 diabetes5.3 SurgeryWe found
Page 119 and 120:
Type 1 diabetesMaintaining hydratio
Page 121 and 122:
Type 1 diabetesdiagnosed at or befo
Page 123 and 124:
Type 1 diabetesA consensus guidelin
Page 125 and 126:
Type 1 diabetespeople with optimal
Page 127 and 128:
Type 1 diabetesIn children under th
Page 129 and 130:
Type 1 diabetesand venlafaxine (sel
Page 131 and 132:
Type 1 diabetesSummaryYoung women w
Page 133 and 134:
Type 1 diabeteschildren and young p
Page 135 and 136:
Type 1 diabetesA theoretical model
Page 137 and 138:
Type 1 diabetesAnother RCT compared
Page 139 and 140:
Type 1 diabetesYoung people with ty
Page 141 and 142:
7. Continuity of care7.1 Communicat
Page 143 and 144:
Type 1 diabetesRESEARCH RECOMMENDAT
Page 145 and 146:
Type 1 diabetesYoung people with ty
Page 147 and 148:
Type 1 diabetesRecommendation Crite
Page 150 and 151:
Appendix AType 1 diabetes in childr
Page 152 and 153:
Appendix ASometimes, it’s possibl
Page 154 and 155:
Appendix AChildren’s diabetes car
Page 156 and 157:
Appendix AIf a child or young perso
Page 158 and 159:
Appendix Aperson who has multiple d
Page 160 and 161:
Appendix A• Providing they are aw
Page 162 and 163:
Appendix Aespecially linked to chil
Page 164 and 165:
Appendix AFor further information a
Page 166 and 167:
Appendix BClinical evidence forest
Page 168 and 169:
Appendix BFigure B.3 HbA 1c - studi
Page 170 and 171:
Appendix BFigure B.5 Hypoglycaemic
Page 172 and 173:
Appendix BFigure B.7 Patient prefer
Page 174 and 175:
Appendix CYoung people’s consulta
Page 176 and 177:
Appendix DManagement of diabetic ke
Page 178 and 179:
Appendix DA. General:Always accept
Page 180 and 181:
Appendix D• staffing levels on th
Page 182 and 183:
Appendix D• If needed, a solution
Page 184 and 185:
Appendix DAPPENDIX 1Glasgow Coma Sc
Page 186 and 187:
References1. Smith AHK. The Nationa
Page 188 and 189:
References59. Satman I, Dinccag N,
Page 190 and 191:
References2003 [unpublished].121. N
Page 192 and 193:
Referencesinsulin lispro in continu
Page 194 and 195:
Referencesin diabetic patients. Ann
Page 196 and 197:
References301. Kilpatrick ES. Probl
Page 198 and 199:
References367. Marrero DG, Kronz KK
Page 200 and 201:
References428. Donaghue KC, Pena MM
Page 202 and 203:
References496. Edge JA, Ford-Adams
Page 204 and 205:
References1995;38:607-11.562. Morte
Page 206 and 207:
References627. Harrison-Woolrych M,
Page 208 and 209:
Indexacademic achievement 114acarbo
Page 210 and 211:
Indexdiagnosis 22-4, 134-5algorithm
Page 212 and 213:
Indexrecommendations 13, 88immunoth
Page 214 and 215:
Indexneonates (newborn babies) 6, 1
Page 216:
Indexsuicide 111sulphonylureas 64-5
show all

Type 1 diabetes - redGDPS

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?